Chaoju Eye Care Holdings Limited (HKG:2219)
Hong Kong · Delayed Price · Currency is HKD 2.710
-0.020 (-0.73%)
Sep 12, 2025, 4:08 PM HKT
Chaoju Eye Care Holdings Revenue
Chaoju Eye Care Holdings had revenue of 698.26M CNY in the half year ending June 30, 2025, with 0.80% growth. This brings the company's revenue in the last twelve months to 1.37B, down -2.95% year-over-year. In the year 2024, Chaoju Eye Care Holdings had annual revenue of 1.41B with 2.62% growth.
Revenue (ttm)
1.37B CNY
Revenue Growth
-2.95%
P/S Ratio
1.25
Revenue / Employee
525.09K CNY
Employees
2,608
Market Cap
1.87B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.41B | 35.95M | 2.62% |
| Dec 31, 2023 | 1.37B | 379.46M | 38.33% |
| Dec 31, 2022 | 990.04M | -7.74M | -0.78% |
| Dec 31, 2021 | 997.79M | 203.51M | 25.62% |
| Dec 31, 2020 | 794.28M | 79.61M | 11.14% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines AG | 35.81B |
| Hansoh Pharmaceutical Group Company | 14.45B |
| JD Health International | 71.34B |
| Innovent Biologics | 12.52B |
| Sino Biopharmaceutical | 33.49B |
| WuXi Biologics | 21.98B |
| CSPC Pharmaceutical Group | 28.49B |
| Akeso | 2.75B |